Related Experiment Video
Updated: Nov 16, 2025

09:36
Author Spotlight: Discovering New Alkaloids in Plants with Advanced Mass Spectrometry Techniques
Published on: March 8, 2024
1.2K
Analytical Considerations When Developing an LC-MS/MS Method for More than 30 Analytes
Jeffrey R Enders1, Jeremy P Smith1, Sheng Feng1
1Research and Development Department, Ameritox, LLC, Greensboro, NC 27409.
The Journal of Applied Laboratory Medicine
|February 27, 2021
Summary
Developing a validated LC-MS/MS method for over 30 analytes requires novel approaches to calibration and controls. This study details a practical method for accurate medication monitoring, optimizing performance and minimizing risks.
Area of Science:
- Clinical Chemistry
- Analytical Chemistry
- Mass Spectrometry
Background:
- Validation of analytical methods, particularly for numerous analytes using LC-MS/MS, presents unique challenges.
- Conventional approaches for calibration curves, controls, and run time are often insufficient for multi-analyte methods.
- This report addresses the practical design and implementation of a multi-analyte LC-MS/MS method adhering to College of American Pathologists validation criteria.
Purpose of the Study:
- To detail the practical aspects of designing and validating a complex analytical method for over 30 analytes.
- To present a method optimized for quality and accurate medication monitoring.
- To introduce novel approaches for calibration curves and controls to improve performance and reduce risk.
Main Methods:
- A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was designed and validated for 34 analytes and 15 internal standards.
- The design and validation process strictly followed a standard operating procedure consistent with College of American Pathologists criteria.
- Optimization focused on negating interferences, increasing throughput, and ensuring reproducible quantification across relevant concentration ranges.
Main Results:
- The developed LC-MS/MS method provides high-quality results for accurate medication monitoring.
- Interferences from the method and concomitant compounds were successfully negated.
- The method demonstrated increased throughput and reproducible quantification over the desired analyte concentration ranges.
Conclusions:
- The primary goals of quality and accurate medication monitoring were achieved through the developed LC-MS/MS method.
- Novel strategies for calibration curves and controls were employed, enhancing performance and minimizing financial and operational risks.
- Advancements in automation and LC-MS/MS technology are expected to facilitate the development of similar complex analytical methods in the future.

